October 16, 2024 17:00 Non Regulatory Flerie AB’s Nomination Committee for the 2025 Annual General Meeting Read news release
November 20, 2024 Vitara Biomedical Raises $50 Million in Additional Financing and Names Kim Rodriguez as New Chief Executive Officer Read news release
November 18, 2024 Lipum Presents Promising Data on Novel Antibody SOL-116 at ACR 2024 Read news release
November 13, 2024 Microbiotica Announces First Patient Dosed in its Phase 1b Trial (COMPOSER-1) of MB310, a Precision Microbiome Medicine, in Ulcerative Colitis Patients Read news release
